Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Press Release |
CNY | Fiscal Year Ending | | Latest |
(in millions) | | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 0 | 2,172 | 2,890 | 2,944 | 3,118 | 2,182 | 2,000 | 1,450 | 2,823 | 2,917 | | 2,917 |
% Growth | NA | NA | 33.0% | 1.9% | 5.9% | -30.0% | -8.3% | -27.5% | 94.6% | 3.3% | | |
| | | | | | | | | | | | |
Cost of Revenue | 0 | (2,006) | (2,649) | (2,681) | (2,890) | (1,989) | (1,828) | (1,247) | (2,523) | (2,660) | | (2,660) |
Gross Profit | 0 | 166 | 241 | 263 | 227 | 193 | 172 | 204 | 300 | 258 | | 258 |
% Revenue | NA | 7.6% | 8.3% | 8.9% | 7.3% | 8.9% | 8.6% | 14.0% | 10.6% | 8.8% | | 8.8% |
| | | | | | | | | | | | |
Research and Development | 0 | (79) | (103) | (105) | (112) | (113) | (119) | (124) | (140) | (142) | | (142) |
Selling and Marketing | 0 | (22) | (50) | (50) | (42) | (38) | (41) | (39) | (59) | (57) | | (57) |
General and Admin | 0 | (34) | (59) | (65) | (58) | (62) | (59) | (65) | (64) | (77) | | (77) |
Other Inc / (Exp) | 0 | 14 | 11 | 27 | 40 | 54 | 31 | 40 | 27 | 74 | | 74 |
Total Operating Exp | 0 | (120) | (201) | (193) | (172) | (159) | (187) | (188) | (235) | (201) | | (201) |
| | | | | | | | | | | | |
Operating Income | 0 | 46 | 40 | 70 | 56 | 35 | (15) | 16 | 64 | 57 | | 57 |
% Revenue | NA | 2.1% | 1.4% | 2.4% | 1.8% | 1.6% | -0.8% | 1.1% | 2.3% | 1.9% | | 1.9% |
| | | | | | | | | | | | |
Interest Expense | 0 | (1) | (7) | (15) | (11) | (1) | (1) | (6) | (24) | (36) | | (36) |
Pre-tax Income | 0 | 44 | 32 | 55 | 44 | 34 | (16) | 10 | 40 | 20 | | 20 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | 0 | (2) | (0) | (11) | (7) | (3) | (2) | (3) | (9) | (5) | | (5) |
Net Income to Company | 0 | 43 | 32 | 44 | 38 | 31 | (18) | 6 | 31 | 16 | | 16 |
% Margin | NA | 2.0% | 1.1% | 1.5% | 1.2% | 1.4% | -0.9% | 0.4% | 1.1% | 0.5% | | 0.5% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | | 1 |
Net Income to Stockholders | 0 | 43 | 33 | 45 | 39 | 31 | (18) | 7 | 32 | 16 | | 16 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 0 | 43 | 33 | 45 | 39 | 31 | (18) | 7 | 32 | 16 | | 16 |
% Margin | NA | 2.0% | 1.1% | 1.5% | 1.3% | 1.4% | -0.9% | 0.4% | 1.1% | 0.6% | | 0.6% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.00 | 0.32 | 0.20 | 0.07 | 0.05 | 0.03 | (0.02) | 0.01 | 0.03 | 0.02 | | 0.02 |
Diluted EPS (Continuing Ops) | 0.00 | 0.32 | 0.20 | 0.07 | 0.05 | 0.03 | (0.02) | 0.01 | 0.03 | 0.02 | | 0.02 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 0.00 | 135.19 | 163.73 | 680.81 | 783.56 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,002.52 | | 1,002.52 |
WA Diluted Shares Out. | 0.00 | 135.19 | 163.73 | 680.81 | 783.56 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,002.52 | | 1,002.52 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 0 | 44 | 32 | 55 | 44 | 34 | (16) | 10 | 40 | 20 | | 20 |
Addback: Net Interest Expense | 0 | 1 | 7 | 15 | 11 | 1 | 1 | 6 | 24 | 36 | | 36 |
Addback: Other Non Operating Expenses, Total | 0 | (13) | (9) | (5) | (17) | (18) | (11) | (24) | (12) | (74) | | (74) |
Addback: Depreciation & Amortization | 0 | 4 | 9 | 15 | 17 | 19 | 21 | 25 | 14 | 14 | | 14 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | (0) | (1) | (5) | (10) | (7) | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | (0) | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 2 | 0 | 0 | 0 | (2) | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | (17) | (13) | (29) | (18) | (16) | (16) | 0 | | 0 |
Adjusted EBITDA | 0 | 36 | 40 | 58 | 32 | (1) | (26) | 1 | 51 | (3) | | (3) |
% Margin | NA | 1.7% | 1.4% | 2.0% | 1.0% | 0.0% | -1.3% | 0.0% | 1.8% | -0.1% | | -0.1% |
| | | | | | | | | | | | |
Adjusted EBIT | 0 | 33 | 31 | 43 | 15 | (20) | (46) | (24) | 37 | (17) | | (17) |
% Margin | NA | 1.5% | 1.1% | 1.5% | 0.5% | -0.9% | -2.3% | -1.7% | 1.3% | -0.6% | | -0.6% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 0 | 43 | 32 | 44 | 38 | 31 | (18) | 6 | 31 | 16 | | 16 |
Addback: Unusual Items | 0 | (0) | 1 | (22) | (23) | (36) | (20) | (16) | (16) | 0 | | 0 |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | (0) | 6 | 6 | 9 | 5 | 4 | 4 | 0 | | 0 |
Adjusted Net Income | 0 | 42 | 33 | 28 | 21 | 4 | (33) | (6) | 19 | 16 | | 16 |
% Margin | NA | 2.0% | 1.1% | 0.9% | 0.7% | 0.2% | -1.6% | -0.4% | 0.7% | 0.5% | | 0.5% |